Supek V, Gamulin S, Delić V
Folia Microbiol (Praha). 1985;30(4):342-8. doi: 10.1007/BF02927588.
DL-4-Azaleucine-resistant mutant of Bacillus licheniformis azlr-1 isolated after N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis, was a better bacitracin producer than the parent strain. In the minimal medium, the antibiotic biosynthesis was 4 times higher in the mutant than in the parent strain and less dependent on L-leucine addition. In the complex fermentation medium, the yield was 18-20% higher in the mutant strain. Transaminase B activity measured in the crude extract revealed that the branched-chain amino acid biosynthetic enzymes were 5-10 times derepressed supplying bacitracin synthetase with enhanced quantity of isoleucine and leucine, the building units of bacitracin molecule.
地衣芽孢杆菌的DL - 4 - 氮杂亮氨酸抗性突变体azlr - 1是经N - 甲基 - N'- 硝基 - N - 亚硝基胍诱变后分离得到的,它比亲本菌株更能高效生产杆菌肽。在基本培养基中,该突变体的抗生素生物合成量比亲本菌株高4倍,且对添加L - 亮氨酸的依赖性较小。在复合发酵培养基中,突变菌株的产量高出18 - 20%。对粗提取物中测得的转氨酶B活性表明,支链氨基酸生物合成酶的阻遏解除了5 - 10倍,为杆菌肽合成酶提供了更多数量的异亮氨酸和亮氨酸,而它们是杆菌肽分子的组成单元。